Physician profile
Diane Zanger
NPI 1760488696
$5,215.16
in general payments reported to CMS, 2019-2025
42 companies · $1,090 in 2025
The $1,090 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $419 · 2021: $865 · 2022: $529 · 2023: $532 · 2024: $1,211 · 2025: $1,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,832.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $899.68 | 2019-2025 | |
| Amgen INC. | $510.13 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $334.04 | 2019-2025 | Camzyos, Eliquis |
| Baxter Healthcare | $286.54 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Merck Sharp & Dohme LLC | $277.74 | 2022-2025 | Verquvo, Capvaxive, Steglatro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $260.72 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $246.23 | 2019-2024 | Watchman Flx |
| Medtronic Vascular, INC. | $196.05 | 2020 | |
| Heartflow, INC. | $189.61 | 2023-2025 | Ffrct |
| Astrazeneca Pharmaceuticals LP | $177.32 | 2019-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $173.59 | 2019 | |
| Pfizer INC. | $159.00 | 2019-2025 | |
| Vifor Pharma, INC. | $140.04 | 2019-2024 | Veltassa |
| Cvrx, INC. | $139.09 | 2024 | Barostim Neo System |
| Amarin Pharma, INC. | $139.08 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Zanger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.